Cisen Pharmaceutical Co., Ltd. provided earnings guidance for the first half of 2018. According to preliminary statistics of its financial department, the Company predicts the net profit owned by shareholders of the listed company in the 1st half of 2018 to be between RMB 217,144,200 and RMB 242,690,600, with an increase of between RMB 89,412,300 and RMB 114,958,700 compared with the same period of the year before and a year-on-year increase of between 70% and 90%. The net profit belonging to shareholders of the listed company after excluding extraordinary profit and loss will be between RMB 206,007,500 and RMB 228,897,200, with an increase of between RMB 91,558,900 and RMB 114,448,600 compared with the same period of the year before and a year-on-year increase of between 80% and 100%.